Role of Programmed Death Ligand 1 in Colorectal Cancer
ConditionColo-rectal Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
1. \- Evaluation of diagnostic importance of soluble programmed death ligand-1 in patient with recently diagnosed as Colorectal cancer at different stages of disease . 2. Correlation of SPDL-1 level and clinco-pathological data of patients at presentation .
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Cases and controls will be recruited from clinical pathology department at South Egypt Cancer Institute, and Assuit University Hospital
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
elisa
Diagnostic testenzyme- linked immunesorbent assay ( ELISA ) was used to measure soluble programmed death ligand-1 level
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Study the expression level of sPDL 1 in colorectal cancer by ELISA
Correlate the expression level of sPDL-1 and stage of disease
Time frame
baselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: